The Perelman School of Medicine’s Sunil Singhal comments on studying how to make tumors glow in order to find cancer.
Health & Medicine
Penn Medicine and Wistar Receive $12 Million NCI Melanoma Grant to Help Fast Track Lab Discoveries into Treatments
Penn Medicine and The Wistar Institute have been awarded a prestigious $12.1 million SPORE grant from the National Cancer Institute.
Researchers in the Pennsylvania Muscle Institute (PMI), based at the Perelman School of Medicine at the University of Pennsylvania have received $9 million over the next five years from the National Institute of General Medical Sciences to investigate the biology of cellular motors.
Research from the Perelman School of Medicine’s Pooja Mehta and Mark Pauly of the Wharton School is cited.
Amy Clark, Robert Vonderheide, Angela DeMichele and Martha Sweeney of the Perelman School of Medicine are quoted about new advances for cancer clinical trials.
Penn Medicine: Zebrafish Model of a Learning and Memory Disorder Shows Better Way to Target Treatment
Using a zebrafish model of a human genetic disease called neurofibromatosis (NF1), a team from the Perelman School of Medicine at the University of Pennsylvania has found that the learning and memory components of the disorder are distinct features that will likely need different treatment approaches.
Penn Medicine Study Reveals Profile of Patients Most Likely to Delay Hospice Enrollment Until Final Days of Life
One in six cancer patients enroll in hospice only during their last three days of life, according to a new study from a team from the Perelman School of Medicine at the University of Pennsylvania.
The University of Pennsylvania today reached an important milestone in its alliance with Novartis as it unveiled plans for the construction of a first-of-its-kind Center for Advanced Cellular Therapeutics (CACT) on the Penn Medicine campus in Philadelphia.